Perceptive Advisors as of June 30, 2011
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 74 positions in its portfolio as reported in the June 2011 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 5.7 | $21M | 344k | 60.32 | |
Varian Medical Systems | 5.2 | $19M | 270k | 70.02 | |
United Therapeutics Corporation (UTHR) | 5.1 | $19M | 340k | 55.10 | |
UnitedHealth (UNH) | 5.0 | $18M | 353k | 51.58 | |
Neurocrine Biosciences (NBIX) | 4.9 | $18M | 2.2M | 8.05 | |
Aegerion Pharmaceuticals | 4.9 | $18M | 1.1M | 15.75 | |
Express Scripts | 4.1 | $15M | 279k | 53.98 | |
D Alexion Pharmaceutic Als Inc C Common Stock 0 | 4.1 | $15M | 320k | 47.03 | |
Spdr S&p 500 Etf (SPY) | 3.6 | $13M | 100k | 131.97 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.5 | $13M | 250k | 51.99 | |
Shire | 3.1 | $11M | 120k | 94.21 | |
InterMune | 2.9 | $11M | 300k | 35.85 | |
Valeant Pharmaceuticals Int | 2.8 | $10M | 200k | 52.05 | |
Ariad Pharmaceuticals | 2.8 | $10M | 895k | 11.33 | |
Dendreon Corporation | 2.7 | $9.9M | 250k | 39.44 | |
NPS Pharmaceuticals | 2.4 | $8.8M | 929k | 9.45 | |
Repros Therapeutics | 2.3 | $8.3M | 1.6M | 5.35 | |
Examworks | 2.0 | $7.5M | 296k | 25.39 | |
Capital Senior Living Corporation | 2.0 | $7.2M | 776k | 9.29 | |
Biogen Idec (BIIB) | 1.9 | $7.1M | 66k | 106.92 | |
Caliper Life Sciences | 1.9 | $6.8M | 844k | 8.11 | |
AVI BioPharma ComStk Usd0.0001 | 1.7 | $6.1M | 4.3M | 1.43 | |
Allergan Inc Com Stk | 1.6 | $5.8M | 70k | 83.26 | |
Pharmasset | 1.2 | $4.5M | 40k | 112.20 | |
Pharmacyclics | 1.2 | $4.5M | 430k | 10.44 | |
Endocyte | 1.2 | $4.3M | 298k | 14.32 | |
Athersys | 1.1 | $4.1M | 1.5M | 2.71 | |
Gilead Sciences (GILD) | 1.0 | $3.8M | 92k | 41.41 | |
Chelsea Therapeutics International | 1.0 | $3.8M | 740k | 5.10 | |
Cubist Pharmaceuticals | 1.0 | $3.6M | 100k | 35.99 | |
ProAssurance Corporation (PRA) | 1.0 | $3.5M | 50k | 70.00 | |
EXACT Sciences Corporation (EXAS) | 0.9 | $3.3M | 389k | 8.60 | |
Neptune Technologies Bioreso | 0.9 | $3.2M | 855k | 3.74 | |
Salix Pharmaceuticals | 0.8 | $2.8M | 70k | 39.83 | |
Savient Pharmaceuticals | 0.7 | $2.7M | 360k | 7.49 | |
WuXi PharmaTech | 0.7 | $2.5M | 145k | 17.56 | |
Response Genetics (RGDXQ) | 0.7 | $2.5M | 908k | 2.77 | |
Aetna | 0.6 | $2.3M | 53k | 44.10 | |
Medical Properties Trust (MPW) | 0.6 | $2.3M | 200k | 11.50 | |
Biodel | 0.6 | $2.3M | 1.2M | 1.87 | |
Solta Medical | 0.6 | $2.2M | 794k | 2.76 | |
Icagen (ICGN) | 0.6 | $2.1M | 350k | 6.10 | |
Auxilium Pharmaceuticals | 0.5 | $2.0M | 100k | 19.60 | |
Thoratec Corporation | 0.5 | $2.0M | 60k | 32.82 | |
ViroPharma Incorporated | 0.5 | $1.9M | 100k | 18.50 | |
Rigel Pharmaceuticals (RIGL) | 0.5 | $1.8M | 200k | 9.17 | |
Immunomedics | 0.5 | $1.8M | 448k | 4.07 | |
Exelixis (EXEL) | 0.5 | $1.8M | 200k | 8.96 | |
Anthera Pharmaceuticals | 0.5 | $1.8M | 218k | 8.17 | |
Uroplasty | 0.4 | $1.6M | 215k | 7.50 | |
Trius Therapeutics | 0.4 | $1.6M | 201k | 7.92 | |
Trinity Biotech | 0.3 | $1.2M | 117k | 9.94 | |
Onyx Pharmaceuticals | 0.3 | $1.1M | 30k | 35.30 | |
Cynosure | 0.2 | $898k | 74k | 12.10 | |
Cadence Pharmaceuticals | 0.2 | $920k | 100k | 9.20 | |
Affymax (AFFY) | 0.2 | $859k | 125k | 6.87 | |
Raptor Pharmaceutical | 0.2 | $758k | 123k | 6.19 | |
Somaxon Pharmaceuticals | 0.2 | $655k | 308k | 2.13 | |
Mindray Medical International | 0.1 | $561k | 20k | 28.05 | |
IRIS International | 0.1 | $563k | 56k | 9.99 | |
Vascular Solutions | 0.1 | $496k | 40k | 12.40 | |
GTx | 0.1 | $515k | 108k | 4.79 | |
Star Scientific | 0.1 | $450k | 100k | 4.50 | |
LeMaitre Vascular (LMAT) | 0.1 | $309k | 44k | 7.07 | |
K-V Pharmaceutical Company | 0.1 | $272k | 100k | 2.72 | |
ProShares Ultra S&P500 (SSO) | 0.1 | $264k | 5.0k | 52.80 | |
Corcept Therapeutics Incorporated (CORT) | 0.1 | $229k | 58k | 3.98 | |
RTI Biologics | 0.1 | $170k | 63k | 2.70 | |
ArQule | 0.0 | $125k | 20k | 6.25 | |
Sanofi Aventis Wi Conval Rt | 0.0 | $121k | 50k | 2.42 | |
Senesco Technologies | 0.0 | $63k | 223k | 0.28 | |
Progenics Pharmaceuticals | 0.0 | $54k | 7.5k | 7.20 | |
Dynavax Technologies Corporation | 0.0 | $28k | 10k | 2.80 | |
Combimatrix Corporation *w exp 05/01/201 | 0.0 | $0 | 50k | 0.00 |